REPRISE III: REpositionable Percutaneous Replacement of Stenotic Aortic Valve through Implantation of Lotus Valve System – Randomized Clinical Evaluation, January 2016 Continued Access Enrollment

Trial ID or NCT#

NCT02202434

Status

recruiting iconRECRUITING

Purpose

The objective of this study is to evaluate the safety and effectiveness of the Lotus™ Valve System for transcatheter aortic valve replacement (TAVR) in symptomatic subjects with calcific, severe native aortic stenosis who are considered at extreme or high risk for surgical valve replacement.

Investigator(s)

Alan C. Yeung, MD
Michael Fischbein, MD
William Fearon, MD
D. Craig Miller, MD
SEND MESSAGE

View on ClinicalTrials.gov